Search
Close this search box.
Search
Close this search box.

South Africa

Floship Becomes Second Recipient of Investment from FedEx Innovation Lab

The investment marks a significant milestone and signals a new era in the development of the future of global circular e-commerce fulfillment services. HONG KONG, June 19, 2023 (GLOBE NEWSWIRE) — Leading global circular supply chain solutions provider, Floship, has announced today that it has received an investment from FedEx

FedEx and Floship Form Commercial Partnership to Deliver What’s Next in E-Commerce

Investment from FedEx Innovation Lab and innovative collaboration strengthens FedEx end-to-end digital fulfillment and returns solution HONG KONG, June 13, 2023 (GLOBE NEWSWIRE) — FedEx Corp. (NYSE: FDX) and Floship, a leading global circular supply chains solutions provider for e-commerce brands, today announced a partnership designed to provide enhanced fulfillment

Sevenstep Launches Talent Acquisition Assessment Service: Talent Unbounded®

BOSTON, June 13, 2023 (GLOBE NEWSWIRE) — Sevenstep, a global talent solutions leader, today announced the launch of Talent Unbounded®, its talent acquisition assessment and consulting service. Based on more than fifteen years of experience meeting hard-to-fill, high-value talent needs for top global enterprises and mid-market organizations, Talent Unbounded provides

LeddarTech, a Disruptive Automotive Software Provider, to Become a Public Company Via Business Combination With Prospector Capital Corp.

LeddarTech has the potential to disrupt the markets for Advanced Driver Assistance Systems (“ADAS”) and Autonomous Driving (“AD”) with patented low-level sensor fusion and perception software products. LeddarTech’s unique solution solves current limitations, enabling leading automotive original equipment manufacturers (“OEMs”) and Tier 1-2 suppliers to drive ADAS and AD to

Ascendis Pharma Showcases Its Latest Endocrinology Programs, Data, and Research at ENDO 2023

– Endocrinology clinical development progress and research in growth hormone deficiency, hypoparathyroidism, achondroplasia, and Turner Syndrome will be highlighted – Phase 3 Week 52 data for TransCon™ PTH in adults with hypoparathyroidism selected for oral presentation COPENHAGEN, Denmark, June 13, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today

RECENT NEWS

Copyright © 2024 Pakistan Press Release Point. All rights reserved.